A Dose-regimen Finding Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oratecan in Subjects With Advanced Malignancies
Clinical trial NCT02250157 · COMPLETED
Trial details
- NCT number
- NCT02250157
- Sponsor
- Athenex, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-05
- Primary completion
- 2020-03-04
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.